BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Endosc. Nov 16, 2025; 17(11): 111117
Published online Nov 16, 2025. doi: 10.4253/wjge.v17.i11.111117
Table 1 Comparison of the clinical data of the end-to-side anastomosis and side-to-side anastomosis groups, n (%)
Parameter
Group ESA
Group SSA
χ²
P value
n = 334146 (43.7)188 (56.3)
Age (year)0.1830.669
≤ 6071 (48.6) 87 (46.3)
> 6075 (51.4) 101 (53.7)
Sex0.0010.991
Male90 (61.6) 116 (62.7)
Female56 (38.4) 72 (38.3)
Patient center0.8580.354
Xiamen42 (28.8)63 (33.5)
Fuzhou104 (71.2)125 (66.5)
BMI (kg/m2)3.7280.054
≤ 2256 (38.4)92 (48.9)
> 2290 (61.6)96 (51.1)
Tumor location3.1710.075
Descending39 (26.7) 47 (36.7)
Descending-sigmoid junction107 (73.3) 81 (63.3)
TNM stage0.0720.789
II86 (58.9)108 (57.4)
III60 (41.1)80 (42.6)
Histological differentiation0.6520.419
Medium/high 128 (87.7)159 (84.6)
Low/mucinous/signet ring cell carcinoma18 (12.3)29 (15.4)
Size of primary tumor (cm)2.4140.12
≤ 5.0102 (69.9)116 (61.7)
> 5.044 (30.1)72 (38.3)
High ligation inferior mesenteric artery2.5690.109
Yes75 (51.4)80 (42.6)
No71 (48.6)108 (57.4)
Preoperative intestinal obstruction0.0030.96
Yes23 (15.8)30 (16.0)
No123 (84.2)158 (84.0)
CEA (ng/mL)0.7950.373
≤ 5.091 (62.3)126 (67.0)
> 5.055 (37.7)62 (33.0)
Hb (g/L)3.4950.062
≤ 109 (6.2)23 (12.2)
> 10137 (93.8)165 (87.8)≤ 0.001
Postoperative chemotherapy (half a year)0.0320.858
Yes77 (52.7)101 (53.7)
No69 (47.3)87 (46.3)


Write to the Help Desk